Kairus K Tarapore's most recent trade in Xylem Inc was a trade of 401 Common Stock done at an average price of $99.5 . Disclosure was reported to the exchange on March 5, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xylem | Kairus K. Tarapore | SVP & CHRO | Sale of securities on an exchange or to another person at price $ 99.53 per share. | 05 Mar 2021 | 401 | 14,409 (0%) | 0% | 99.5 | 39,912 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 6,843 | 6,843 | - | - | Stock Option (Right to Buy) | |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Sale of securities on an exchange or to another person at price $ 99.95 per share. | 26 Feb 2021 | 2,777 | 13,506 (0%) | 0% | 99.9 | 277,561 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 1,553 | 14,810 (0%) | 0% | 0 | Common Stock | |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.23 per share. | 26 Feb 2021 | 249 | 13,257 (0%) | 0% | 102.2 | 25,455 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2021 | 3,192 | 17,500 (0%) | 0% | 0 | Common Stock | |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.48 per share. | 20 Feb 2021 | 1,217 | 16,283 (0%) | 0% | 99.5 | 121,067 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.48 per share. | 20 Feb 2021 | 304 | 14,563 (0%) | 0% | 99.5 | 30,242 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 99.48 per share. | 20 Feb 2021 | 255 | 14,308 (0%) | 0% | 99.5 | 25,367 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 8,138 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Sale of securities on an exchange or to another person at price $ 91.15 per share. | 05 Nov 2020 | 8,138 | 14,867 (0%) | 0% | 91.2 | 741,780 | Common Stock |
| Xylem | Kairus K. Tarapore | SVP & CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.85 per share. | 05 Nov 2020 | 8,138 | 23,005 (0%) | 0% | 33.8 | 275,471 | Common Stock |